Vir Biotechnology Inc
Biotechnology
Healthcare
VIR
137 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
5.05
52 week high
12.48
high
6.02
52 week low
5.19
low
4.95
growth
-44.30 %
previous Close
5.19
P/E ratio
-4
market cap
1.02 B
div yield
0
usd
Sep 2024
qoq
revenue
2.38 M
-22.60 %
net incoming
-213.72 M
-54.44 %
eps
-1.56 %
-52.94 %
eps surprise
-48.57 %
net profit margin
-8979.71 %
-4479.00 %
operating incoming
-218.59 M
-68.97 %
net change in cash
-46.48 M
-133.99 %
cash on hand
258 M
-17.01 %
cost of revenue
50.00 K
-98.84 %
top top